{"id":6251,"date":"2025-03-10T06:34:50","date_gmt":"2025-03-10T06:34:50","guid":{"rendered":"https:\/\/aceoncology.org\/?post_type=ace_event&#038;p=6251"},"modified":"2025-03-11T06:18:31","modified_gmt":"2025-03-11T06:18:31","slug":"preceptorship-in-urothelial-cancer-2025","status":"publish","type":"ace_event","link":"https:\/\/aceoncology.org\/zh-hans\/event\/preceptorship-in-urothelial-cancer-2025\/","title":{"rendered":"Preceptorship in Urothelial Cancer"},"content":{"rendered":"\n<p>The therapeutic landscape for urothelial cancer (UC) has undergone significant transformation in recent years, with the addition of PD-1\/PD-L1 targeting immune checkpoint inhibitors (ICI) and novel targeted therapies and antibody-drug conjugates (ADCs) adding to the complexity of treatment options available for patients throughout the course of their disease. The optimal sequencing of treatments depends on an understanding of the relevance of different pathological subtypes of the disease and of the latest clinical evidence and guidelines that support the use of different therapies.<\/p>\n\n\n\n<div class=\"wp-block-group is-layout-flex wp-block-group-is-layout-flex\"><\/div>\n\n\n\n<p>In this 2-day \u2018Preceptorship in Urothelial Cancer\u2019, which is an in-depth interactive program of didactic lectures, case discussions, and clinical research evaluation, attendees will receive a detailed grounding of the disease process and management from diagnosis through to salvage treatments of advanced disease. The course will enable clinicians who are involved in the management of patients with urothelial cancer to integrate the latest advances and use of novel therapies for advanced urothelial cancer into safe and effective patient care.<\/p>\n\n\n\n<div class=\"wp-block-group is-layout-flex wp-block-group-is-layout-flex\">\n<div class=\"wp-block-group is-layout-flex wp-block-group-is-layout-flex\"><\/div>\n\n\n\n<div class=\"wp-block-group is-layout-flex wp-block-group-is-layout-flex\"><\/div>\n<\/div>\n\n\n\n<p><em>For more information and to register for this program, please contact: <\/em><\/p>\n\n\n\n<p><a href=\"mailto:info_aceoncology@aceoncology.org\">info_aceoncology@aceoncology.org<\/a><\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The therapeutic landscape for urothelial cancer (UC) ha [&hellip;]<\/p>\n","protected":false},"author":691,"featured_media":6275,"template":"","ace_event_category":[92],"ace_event_tag":[],"class_list":["post-6251","ace_event","type-ace_event","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Preceptorship in Urothelial Cancer - ACE Oncology<\/title>\n<meta name=\"description\" content=\"Join experts in the field of genitourinary cancer discuss the management of patients with urothelial cancer in this live meeting in Madrid, Spain.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/aceoncology.org\/zh-hans\/event\/preceptorship-in-urothelial-cancer-2025\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Preceptorship in Urothelial Cancer - ACE Oncology\" \/>\n<meta property=\"og:description\" content=\"Join experts in the field of genitourinary cancer discuss the management of patients with urothelial cancer in this live meeting in Madrid, Spain.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/aceoncology.org\/zh-hans\/event\/preceptorship-in-urothelial-cancer-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"ACE Oncology\" \/>\n<meta property=\"article:modified_time\" content=\"2025-03-11T06:18:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/aceoncology.org\/wp-content\/uploads\/2025\/03\/Website-Thumbnail-721x450px_Website-Thumbnail-721x450px-1-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1502\" \/>\n\t<meta property=\"og:image:height\" content=\"938\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@ace_oncology\" \/>\n<meta name=\"twitter:label1\" content=\"\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 \u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/event\/preceptorship-in-urothelial-cancer-2025\/\",\"url\":\"https:\/\/aceoncology.org\/zh-hans\/event\/preceptorship-in-urothelial-cancer-2025\/\",\"name\":\"Preceptorship in Urothelial Cancer - ACE Oncology\",\"isPartOf\":{\"@id\":\"https:\/\/aceoncology.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/event\/preceptorship-in-urothelial-cancer-2025\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/event\/preceptorship-in-urothelial-cancer-2025\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2025\/03\/Website-Thumbnail-721x450px_Website-Thumbnail-721x450px-1-1.png\",\"datePublished\":\"2025-03-10T06:34:50+00:00\",\"dateModified\":\"2025-03-11T06:18:31+00:00\",\"description\":\"Join experts in the field of genitourinary cancer discuss the management of patients with urothelial cancer in this live meeting in Madrid, Spain.\",\"breadcrumb\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/event\/preceptorship-in-urothelial-cancer-2025\/#breadcrumb\"},\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/aceoncology.org\/zh-hans\/event\/preceptorship-in-urothelial-cancer-2025\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/event\/preceptorship-in-urothelial-cancer-2025\/#primaryimage\",\"url\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2025\/03\/Website-Thumbnail-721x450px_Website-Thumbnail-721x450px-1-1.png\",\"contentUrl\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2025\/03\/Website-Thumbnail-721x450px_Website-Thumbnail-721x450px-1-1.png\",\"width\":1502,\"height\":938},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/event\/preceptorship-in-urothelial-cancer-2025\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"ACE Oncology\",\"item\":\"https:\/\/aceoncology.org\/zh-hans\/chinese-home\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Events\",\"item\":\"https:\/\/aceoncology.org\/zh-hans\/event\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Preceptorship in Urothelial Cancer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/aceoncology.org\/#website\",\"url\":\"https:\/\/aceoncology.org\/\",\"name\":\"ACE Oncology\",\"description\":\"ACE Oncology is a global independent medical education resource that provides evidence-based, high-quality educational solutions for clinicians that treat patients with cancer.\",\"publisher\":{\"@id\":\"https:\/\/aceoncology.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/aceoncology.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/aceoncology.org\/#organization\",\"name\":\"ACE Oncology\",\"url\":\"https:\/\/aceoncology.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/05\/Logo.png\",\"contentUrl\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/05\/Logo.png\",\"width\":156,\"height\":83,\"caption\":\"ACE Oncology\"},\"image\":{\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/ace_oncology\",\"https:\/\/www.linkedin.com\/company\/aceoncology\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Preceptorship in Urothelial Cancer - ACE Oncology","description":"Join experts in the field of genitourinary cancer discuss the management of patients with urothelial cancer in this live meeting in Madrid, Spain.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/aceoncology.org\/zh-hans\/event\/preceptorship-in-urothelial-cancer-2025\/","og_locale":"zh_CN","og_type":"article","og_title":"Preceptorship in Urothelial Cancer - ACE Oncology","og_description":"Join experts in the field of genitourinary cancer discuss the management of patients with urothelial cancer in this live meeting in Madrid, Spain.","og_url":"https:\/\/aceoncology.org\/zh-hans\/event\/preceptorship-in-urothelial-cancer-2025\/","og_site_name":"ACE Oncology","article_modified_time":"2025-03-11T06:18:31+00:00","og_image":[{"width":1502,"height":938,"url":"https:\/\/aceoncology.org\/wp-content\/uploads\/2025\/03\/Website-Thumbnail-721x450px_Website-Thumbnail-721x450px-1-1.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@ace_oncology","twitter_misc":{"\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4":"2 \u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/aceoncology.org\/zh-hans\/event\/preceptorship-in-urothelial-cancer-2025\/","url":"https:\/\/aceoncology.org\/zh-hans\/event\/preceptorship-in-urothelial-cancer-2025\/","name":"Preceptorship in Urothelial Cancer - ACE Oncology","isPartOf":{"@id":"https:\/\/aceoncology.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/aceoncology.org\/zh-hans\/event\/preceptorship-in-urothelial-cancer-2025\/#primaryimage"},"image":{"@id":"https:\/\/aceoncology.org\/zh-hans\/event\/preceptorship-in-urothelial-cancer-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/aceoncology.org\/wp-content\/uploads\/2025\/03\/Website-Thumbnail-721x450px_Website-Thumbnail-721x450px-1-1.png","datePublished":"2025-03-10T06:34:50+00:00","dateModified":"2025-03-11T06:18:31+00:00","description":"Join experts in the field of genitourinary cancer discuss the management of patients with urothelial cancer in this live meeting in Madrid, Spain.","breadcrumb":{"@id":"https:\/\/aceoncology.org\/zh-hans\/event\/preceptorship-in-urothelial-cancer-2025\/#breadcrumb"},"inLanguage":"zh-Hans","potentialAction":[{"@type":"ReadAction","target":["https:\/\/aceoncology.org\/zh-hans\/event\/preceptorship-in-urothelial-cancer-2025\/"]}]},{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/aceoncology.org\/zh-hans\/event\/preceptorship-in-urothelial-cancer-2025\/#primaryimage","url":"https:\/\/aceoncology.org\/wp-content\/uploads\/2025\/03\/Website-Thumbnail-721x450px_Website-Thumbnail-721x450px-1-1.png","contentUrl":"https:\/\/aceoncology.org\/wp-content\/uploads\/2025\/03\/Website-Thumbnail-721x450px_Website-Thumbnail-721x450px-1-1.png","width":1502,"height":938},{"@type":"BreadcrumbList","@id":"https:\/\/aceoncology.org\/zh-hans\/event\/preceptorship-in-urothelial-cancer-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"ACE Oncology","item":"https:\/\/aceoncology.org\/zh-hans\/chinese-home\/"},{"@type":"ListItem","position":2,"name":"Events","item":"https:\/\/aceoncology.org\/zh-hans\/event\/"},{"@type":"ListItem","position":3,"name":"Preceptorship in Urothelial Cancer"}]},{"@type":"WebSite","@id":"https:\/\/aceoncology.org\/#website","url":"https:\/\/aceoncology.org\/","name":"ACE Oncology","description":"ACE Oncology is a global independent medical education resource that provides evidence-based, high-quality educational solutions for clinicians that treat patients with cancer.","publisher":{"@id":"https:\/\/aceoncology.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/aceoncology.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-Hans"},{"@type":"Organization","@id":"https:\/\/aceoncology.org\/#organization","name":"ACE Oncology","url":"https:\/\/aceoncology.org\/","logo":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/aceoncology.org\/#\/schema\/logo\/image\/","url":"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/05\/Logo.png","contentUrl":"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/05\/Logo.png","width":156,"height":83,"caption":"ACE Oncology"},"image":{"@id":"https:\/\/aceoncology.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/ace_oncology","https:\/\/www.linkedin.com\/company\/aceoncology"]}]}},"_links":{"self":[{"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/ace_event\/6251","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/ace_event"}],"about":[{"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/types\/ace_event"}],"author":[{"embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/users\/691"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/media\/6275"}],"wp:attachment":[{"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/media?parent=6251"}],"wp:term":[{"taxonomy":"ace_event_category","embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/ace_event_category?post=6251"},{"taxonomy":"ace_event_tag","embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/ace_event_tag?post=6251"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}